๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Neuroleptic malignant-like syndrome associated with acute hydrocephalus

โœ Scribed by Chin-Song Lu; Shan-Jin Ryu

Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
458 KB
Volume
6
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Neuroleptic malignant syndrome with olan
Neuroleptic malignant syndrome with olanzapine associated with severe hypernatremia
โœ M. Samir Arnaout; Fouad P. Antun; Khalil Ashkar ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 39 KB

A 30-year-old white man with schizophrenia developed anorexia and nausea, and was admitted to hospital for confusion and delirium. He was on olanzapine, 10 days prior to admission. On admission, typical neuroleptic malignant syndrome (NMS) developed with elevated body temperature (39.7 degrees C), o

Neuroleptic malignant-like syndrome indu
Neuroleptic malignant-like syndrome induced by metoclopramide
โœ Dr. M. Reza Samie ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 275 KB

A prompt recognition of neuroleptic malignant-like syndrome is essential because of its high morbidity and mortality. A similar condition is described associated with metoclopramide, an agent with dopamine receptorblocking properties. An increased index of suspicion for early diagnosis of this condi

Treatment of neuroleptic malignant syndr
Treatment of neuroleptic malignant syndrome with levodopa
โœ K. Otani; K. Mihara; T. Kondo; M. Okada; S. Kaneko; Y. Fukushima ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 400 KB

Seven consecutive episodes of neuroleptic malignant syndrome in five cases were treated with 50-600 mg/day (mean 342 mg/day) of levodopa. In four episodes active pharmacological treatment was initiated with levodopa, while in the remaining three episodes it was introduced because of poor therapeutic

Neuroleptic malignant syndrome treated w
Neuroleptic malignant syndrome treated with subcutaneous lisuride infusion
โœ M. E. Rodriguez; M. R. Luquin; G. Lera; G. Delgado; J. M. Salazar; Dr. Josรฉ A. O ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 262 KB

## Abstract A schizophrenic patient developed a characteristic clinical picture of neuroleptic malignant syndrome (NMS) while admitted to the hospital during an exacerbation of his psychiatric symptoms. Oral treatment of the NMS with bromocriptine (7.5 mg/day) or levodopa/carbidopa (125/12.5 mg) pr